Tirzepatide
Product Showcase
Information
Dual-target GLP-1R/GIPR dual agonist Type Ⅱdiabetes, Obesity
SICHUAN DUORUI BIOPHARMACEUTICAL CO., LTD.
Founded in 2018, Chengdu, Sichuan Duorui Biopharma focuses on peptide and Oligonucleotide APIs. We have GMP workshops, large-scale production capacity, offering high-quality, cost-effective products with quick response.
Log in
See all the content and easy-to-use features by logging in or registering!
Log in
Continue as a guest
Log in
Log in
See all the content and easy-to-use features by logging in or registering!
Log in
Language
Resource center
Contact app support
Legal
Home
CPHI Online
Sign up to our Newsletter
